Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
79
FOLD Quote, Financials, Valuation and Earnings
Last price:
$14.25
Seasonality move
:
4.76%
Day range:
$14.21 - $14.26
52-week range:
$5.51 - $14.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.29x
P/B ratio:
19.08x
Volume:
5.9M
Avg. volume:
12.8M
1-year change:
45.56%
Market cap:
$4.4B
Revenue:
$528.3M
EPS (TTM):
-$0.04
Earnings Data
Next earnings date for FOLD
Feb 18
2026
Most recent earnings per share
$0.06
Missed by $0.07
(Nov 4/2025)
Consensus Estimate
$0.12
(Nov 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
FOLD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/18/2026 | Q4 | $179.8M | -- | -- | $0.16 | -- |
| 11/04/2025 | Q3 | $165.7M | $169.1M | $0.06 | $0.12 | -$0.07 |
| 07/31/2025 | Q2 | $146.7M | $154.7M | -$0.08 | $0.02 | -$0.10 |
| 05/01/2025 | Q1 | $136.3M | $125.2M | -$0.07 | $0.08 | -$0.15 |
| 02/19/2025 | Q4 | $147.9M | $149.7M | $0.05 | $0.09 | -$0.04 |
| 11/06/2024 | Q3 | $135M | $141.5M | -$0.02 | $0.05 | -$0.07 |
| 08/08/2024 | Q2 | $121.2M | $126.7M | -$0.05 | $0.02 | -$0.07 |
| 05/09/2024 | Q1 | $111.2M | $110.4M | -$0.16 | -$0.03 | -$0.13 |
| 02/28/2024 | Q4 | $115M | $115.1M | -$0.12 | -$0.04 | -$0.08 |
| 11/08/2023 | Q3 | -- | $103.5M | -$0.07 | -- | -- |
| 08/08/2023 | Q2 | -- | $94.5M | -$0.15 | -- | -- |
| 05/10/2023 | Q1 | -- | $86.3M | -$0.18 | -- | -- |
| 03/01/2023 | Q4 | -- | $88.1M | -$0.20 | -- | -- |
| 11/07/2022 | Q3 | -- | $81.7M | -$0.12 | -- | -- |
| 08/04/2022 | Q2 | -- | $80.7M | -$0.21 | -- | -- |
| 05/09/2022 | Q1 | -- | $78.7M | -$0.30 | -- | -- |
| 02/24/2022 | Q4 | -- | $82.2M | -$0.30 | -- | -- |
| 11/09/2021 | Q3 | -- | $79.5M | -$0.19 | -- | -- |
| 08/05/2021 | Q2 | -- | $77.4M | -$0.19 | -- | -- |
| 05/10/2021 | Q1 | -- | $66.4M | -$0.25 | -- | -- |
| 03/01/2021 | Q4 | -- | $70.6M | -$0.27 | -- | -- |
| 11/05/2020 | Q3 | -- | $67.4M | -$0.25 | -- | -- |
| 08/10/2020 | Q2 | -- | $62.4M | -$0.20 | -- | -- |
| 05/07/2020 | Q1 | -- | $60.5M | -$0.35 | -- | -- |
| 03/02/2020 | Q4 | -- | $55.3M | -$0.35 | -- | -- |
| 11/11/2019 | Q3 | -- | $48.8M | -$0.24 | -- | -- |
| 08/08/2019 | Q2 | -- | $44.1M | -$0.36 | -- | -- |
| 05/08/2019 | Q1 | -- | $34M | -$0.56 | -- | -- |
| 02/28/2019 | Q4 | -- | $32.6M | -$0.41 | -- | -- |
| 11/05/2018 | Q3 | -- | $20.6M | -$0.84 | -- | -- |
| 08/07/2018 | Q2 | -- | $21.3M | -$0.33 | -- | -- |
| 05/08/2018 | Q1 | -- | $16.7M | -$0.28 | -- | -- |
| 02/28/2018 | Q4 | -- | $14.7M | -$0.41 | -- | -- |
| 11/08/2017 | Q3 | -- | $10.9M | -$0.69 | -- | -- |
| 08/07/2017 | Q2 | -- | $7.2M | -$0.34 | -- | -- |
| 05/09/2017 | Q1 | -- | $4.2M | -$0.39 | -- | -- |
| 03/01/2017 | Q4 | -- | $2.8M | -$0.41 | -- | -- |
| 11/07/2016 | Q3 | -- | $2.1M | -$0.33 | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -$0.40 | -- | -- |
| 05/03/2016 | Q1 | -- | -- | -$0.35 | -- | -- |
| 02/26/2016 | Q4 | -- | -- | -$0.34 | -- | -- |
Amicus Therapeutics, Inc. Earnings Questions
-
How Much did Amicus Therapeutics, Inc. Generate in Revenue Last Quarter?
Amicus Therapeutics, Inc. reported $169.1M worth of top line sales in its most recent quarter.
-
Did Amicus Therapeutics, Inc. Beat Earnings Last Quarter?
Amicus Therapeutics, Inc. announced earnings per share of $0.06 which represents a miss of analyst forecast a $0.12 per share.
-
Is Amicus Therapeutics, Inc. Profitable?
Amicus Therapeutics, Inc. reported $147.7M that represents $0.48 per share over the last quarter.
-
What is the Analyst Consensus for Amicus Therapeutics, Inc. EPS Next Year?
Amicus Therapeutics, Inc.'s earnings are forecast to decrease from -$0.18 per share to $0.24 per share next year representing a decrease of -50.71%.
-
When is Amicus Therapeutics, Inc.'s Earnings Date?
Amicus Therapeutics, Inc.'s next earnings date is February 18, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
